Prof. Nicholas Francis
CRP Point of Care testing to reduce antibiotic prescribing in acutely exacerbated COPD patients
Prof. Ivan Gentile
Severity assessment and outcome prediction in the COVID-19 patients
Dr. Carl Llor
The emergence of multi-resistance associated with the overuse of antibiotics during COVID-19 pandemic
Prof. Dag Berild
Antimicrobial stewardship in the time of COVID-19 is vital — AMR still persists and could be height
Dr. Aggy York
Panel Discussion: CRP and Point of Care testing — knowledge sharing from across Europe
Register its Free
Join a panel of experts from across Europe for this compelling webinar presenting a view from the front line in Europe.
90% of respiratory tract infections (RTIs) are viral and therefore antibiotics have no clinical benefit. And yet RTIs are one of the most common reasons for unnecessary antibiotic prescribing. 
The webinar will also showcase the findings of a UK-based multicentre trial called the PACE study, which was published in 2019 in the New England Journal of Medicine and which recommended that CRP point-of-care testing can guide antibiotic therapy in acutely exacerbated chronic obstructive pulmonary disease (COPD). 
- Despite the viral origin of COVID-19, a standard reflex by physicians is to start treatment with antibiotics since cough, fever and radiologic infiltrates are hallmarks of bacterial community-acquired pneumonia, which requires antibiotic treatment. 
- The detection of CRP is of certain value to distinguish whether there is a bacterial infection in the lung. 
- CRP may reflect disease severity and may be an independent predictor of adverse outcomes in COVID-19 patients.     
- Antibiotics should be reserved for the patients with the most severe presentations. 
- Avoid blind or inappropriate use of antibacterial drugs, especially the combination of broad-spectrum antibacterial drugs. 
- The use of CRP point-of-care testing in patients presenting with acute exacerbations of COPD in primary care resulted in a 20.4% absolute reduction of antibiotic prescribing. 
- There are many reasons why European countries launch Antibiotic Stewardship Programs (ASPs), and in the context of COVID-19, an ASP is needed now more than ever.
Professional Blended Learning Continuum
- MyPOCAcademy is an interactive educational resource providing information on the rationale for Point of Care Testing testing and its value, across a number of medical specialities.
- The courses will allow you to enhance your knowledge and skills at your own pace.
- CME-accredited materials and webinars will be available shortly
Assess Your Understanding
- Within each course are test questions that allow you to test your knowledge.
- Interactive patient case studies enable you to view the benefits of Point of Care Testing in real-life clinical scenarios
Convenient Access to Latest POC Information
- MyPOCAcademy is your go-to resource for the latest information related to Point of Care Testing.
- Learning can be accessed at your convenience with the click of a button.
- ↑ CDC. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). April 3, 2020.
- ↑ Luo X, et al. medRxiv. Published online 2020.
- ↑ Tan C, et al. ORCID iD: 0000-0002-2522-4524.
- ↑ Wang L. Médecine et maladies infectieuses. 2020.
- ↑ Li H, et al. Journal of Infection. Published online 2020.
- ↑ Huttner B, et al. COVID-19: Don’t neglect antimicrobial stewardship: principles! Clinical Microbiology and Infection. 2020.
- ↑ Guan W, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20. doi:10.1056/NEJMoa2002032
- ↑ Rawson T, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;2:ciaa530. doi:10.1093/cid/ciaa530.32358954
- ↑ Jin YH, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research. 2020;7:4.
- ↑ Aabenhus R, et al. Cochrane Database of Systematic Reviews. 2014;11. Art. No.: CD010130.
- ↑ Butler CC, et al. C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. New Engl J Med. 2019;381(2):111-120